Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis

Philippe Moreau, Meletios A. Dimopoulos, Paul G Richardson, David S. Siegel, Michele Cavo, Paolo Corradini, Katja C. Weisel, Michel Delforge, Peter O'Gorman, Kevin Song, Christine Chen, Nizar Bahlis, Albert Oriol, Markus Hansson, Martin Kaiser, Pekka Anttila, Reinier Raymakers, Cristina Joao, Gordon Cook, Lars SternasTsvetan Biyukov, Ana Slaughter, Kevin Hong, Jennifer Herring, Xin Yu, Mohamed H. Zaki, Jesus San Miguel

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

Fingeravtryck

Fördjupa i forskningsämnen för ”Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis”. Tillsammans bildar de ett unikt fingeravtryck.

Pharmacology, Toxicology and Pharmaceutical Science